研究

Y. Kobayashi, C. Ambrogio and T. Mitsudomi

Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights

Y. Kobayashi, T. Fujino, M. Nishino, T. Koga, M. Chiba, Y. Sesumi, S. Ohara, M. Shimoji, K. Tomizawa, T. Takemoto and T. Mitsudomi

EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib

T. Koga, Y. Kobayashi, K. Tomizawa, K. Suda, T. Kosaka, Y. Sesumi, T. Fujino, M. Nishino, S. Ohara, M. Chiba, M. Shimoji, T. Takemoto, M. Suzuki, P. A. Janne and T. Mitsudomi

Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study

M. Nishino, K. Suda, Y. Kobayashi, S. Ohara, T. Fujino, T. Koga, M. Chiba, M. Shimoji, K. Tomizawa, T. Takemoto and T. Mitsudomi

Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro

M. Nishio, K. Nakagawa, T. Mitsudomi, N. Yamamoto, T. Tanaka, H. Kuriki, A. Zeaiter and T. Tamura

Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

K. Suda, J. Kim, I. Murakami, L. Rozeboom, M. Shimoji, S. Shimizu, C. J. Rivard, T. Mitsudomi, A. C. Tan and F. R. Hirsch

Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naive Lesions

K. Suda, I. Murakami, H. Yu, J. Kim, A. C. Tan, H. Mizuuchi, L. Rozeboom, K. Ellison, C. J. Rivard, T. Mitsudomi and F. R. Hirsch

CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer